Role of formulations in targeted delivery of m/RNA for vaccines, therapeutics and in vivo gene…
The expanding scope of mRNAbased therapeutics and vaccines has brought formulation science to the forefront, particularly in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Biological E
Biological E, Recbio collaborate to produce HPV9 vaccine
Recbio to complete technology transfer while BE will manufacture HPV9 vaccine for India, UNICEF and PAHO tender markets
India’s bio-economy can reach $ 300 bn, potentially doubling its growth from 2024
Indian Bio-Economy Report 2024 by the Association of Biotechnology Led Enterprises (ABLE) highlights India’s current bioeconomy,…
We have attempted to make the dengue vaccine more affordable than other innovative vaccines
Gary Dubin, President, Global Vaccine Business Unit, Takeda, and Dion Warren, Head of Multi-Country Organization, India &…
Takeda partner with Biological E. to accelerate access to dengue vaccine
The partnership will build upon existing manufacturing capacity for the vaccine at Takeda’s facility in Singen, Germany and…
Biological E and Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
According to respective company sources, Biological E is holding 200 million doses of its COVID-19 vaccine Corbevax, while Bharat…
CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above
CORBEVAX is expected to be available as a Booster dose on the CoWIN App in public and private vaccination centres from August 12,…
Biological E gets WHO nod to be additional facility for making Johnson & Johnson COVID vaccine
The DCGI recently approved Corbevax as a precaution dose for those aged 18 and above
Biological E reduces Corbevax price to Rs 250 a dose
The decision comes within weeks of Biological E receiving the Emergency Use Authorisation (EUA) for children between five and 12…
Government to expedite process of recognition of Biological E Corbevax by other countries
According to an internal document circulated to the members of the Empowered Group-5 on COVID-19 Vaccination, which will be…